Clinically relevant findings.
Open Access
- 15 December 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (12) , 2935-2936
- https://doi.org/10.1172/jci119843
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.Journal of Clinical Investigation, 1997
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Journal of Clinical Investigation, 1997
- ch-IAP1, a Member of the Inhibitor-of-Apoptosis Protein Family, Is a Mediator of the Antiapoptotic Activity of the v-Rel OncoproteinMolecular and Cellular Biology, 1997
- Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expressionOncogene, 1997
- Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB controlProceedings of the National Academy of Sciences, 1997
- Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular TransformationJournal of Biological Chemistry, 1997
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997
- Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.Molecular and Cellular Biology, 1994